Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer

NCT00735904 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung (NSCLC)

Interventions

DRUG: AG-013736
DRUG: gemcitabine
DRUG: cisplatin

Sponsor

Pfizer